Cancer Research UK is today launching a trial to see if male cancer survivors could benefit from hormone replacement therapy (HRT) with testosterone.
Women who use oestrogen-only hormone replacement therapy (HRT) to relieve menopausal symptoms after a hysterectomy have a reduced risk of developing or dying from breast cancer.
Women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer and to die of the disease, according to a study published in the Lancet.
Some forms of hormone replacement therapy increase the risk of endometrial (womb) cancer, according to results from the Million Women Study, published in the Lancet1today.
Some kinds of hormone replacement therapy (HRT) have a much greater effect on a woman’s risk of breast cancer than others, according to landmark research published in the Lancet.